Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience-Reference-Cited by-同舟云学术

Molecular Profiling of Patients With Advanced Colorectal Cancer: Princess Margaret Cancer Centre Experience

Published:2018-03 Issue:1 Volume:17 Page:73-79
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Chiu Joanne W.,Krzyzanowska Monika K.,Serra Stefano,Knox Jennifer J.,Dhani Neesha C.,Mackay Helen,Hedley David,Moore Malcolm,Liu Geoffrey,Burkes Ronald L.,Brezden-Masley Christine,Roehrl Michael H.,Craddock Kenneth J.,Tsao Ming-Sound,Zhang Tong,Yu Celeste,Kamel-Reid Suzanne,Siu Lillian L.,Bedard Philippe L.,Chen Eric X.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference29 articles.

1. ABC of colorectal cancer: epidemiology;Boyle;BMJ,2000

2. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013

3. K-ras mutations and benefit from cetuximab in advanced colorectal cancer;Karapetis;N Engl J Med,2008

4. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status;Van Cutsem;J Clin Oncol,2011

5. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer;Di Nicolantonio;J Clin Oncol,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of vitamin E δ-tocotrienol and aspirin on Wnt signaling in human colon cancer stem cells and in adenoma development in APC min/+ mice;Carcinogenesis;2024-06-15

2. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis;Journal of Medicine and Life;2024-01

3. Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program;Cancers;2023-01-31

4. Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers;Cancers;2022-02-06

5. Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3;Cancer Letters;2022-02